B-hKIT mice

C57BL/6N-Kittm2( (KIT)Bcgen/Bcgen • 112218

B-hKIT mice

Product nameB-hKIT mice
Catalog number112218
Strain nameC57BL/6N-Kittm2( (KIT)Bcgen/Bcgen
Strain backgroundC57BL/6N
AliasesC-Kit, CD117, MASTC, PBT, SCFR

このページで

  • Targeting strategy
  • Phenotypic analysis
  • Efficacy

ポスター

すべて表示

    出版物

      Targeting strategy

      Gene targeting strategy for B-hKIT mice. A chimeric coding sequences of human KIT gene encoding the extracellular region and mouse Kit gene encoding the signal peptide, transmembrane region and the intracellular region were inserted in exon 2 of mouse Kit gene in B-hKIT mice.

      Protein expression analysis

      Strain specific KIT expression analysis in homozygous B-hKIT mice by flow cytometry. Bone marrow were collected from wild-type mice (+/+) and homozygous B-hKIT mice (H/H), and analyzed by flow cytometry with species-specific anti-KIT antibody. Mouse KIT was detectable in wild-type mice. Human KIT was exclusively detectable in homozygous B-hKIT mice but not in wild-type mice.

      Compound 48/80 (C48/80) induced systemic anaphylaxis reaction in B-hKIT mice

      Effects of C48/80‑induced systemic anaphylaxis reaction. (A) Anti‑hKIT antibody briquilimab (25 mpk, commercially purchased) was injected before challenge at week 0. B‑hKIT mice (H/H) (n=3) were challenged with C48/80 at week 1. (B) Body temperature was recorded from 0 to 90 minutes after challenge with 2.5 mg/kg C48/80. Briquilimab, by depleting mast cells, attenuated the decrease in body temperature induced by C48/80, demonstrating its inhibitory effect on the systemic anaphylaxis reaction in B‑hKIT mice.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hKIT mice] (Cat# 112218) was purchased from Biocytogen.